This Week in SaaS

Ian Bambrick
3 min readFeb 11, 2021

Weekly insights on great companies operating within the SaaS space.

If you’re not familiar with SaaS, go check out the beginning portion of my prior article — This Week in SaaS. Weekly insights on great companies… | by Ian Bambrick | Jan, 2021 | Medium

Really this series should be called this week in growth, but I’ll assume readers are privy to the fact this blog is geared towards late stage venture investments! With that being said, let’s jump right into it.

Some big names putting capital to work this past week. Again we see Tiger, and Silver Lake. Index, GGV, Andreessen Horowitz and Goldman Sachs just to name a few others.

As for some of the headlining news pieces:

  • Nexthink receives $180.3 million in funding from Permira, Index Ventures, and Highland Europe. Nexthink allows enterprises to create highly productive digital workplaces for their employees by delivering an optimal end-user experience.
  • Divvy receives $110 million in funding from Tiger Global Management, Moore Capital, Jaws Ventures, GGV Capital, and Andreessen Horowitz. Divvy Homes is a tech-enabled real estate platform that facilitates rent-to-own home purchases, enabling customers to close the housing affordability gap.
  • Kong receives $100 million in funding from Tiger Global Management, Index Ventures, Goldman Sachs, GGV Capital, CRV, and Andreessen Horowitz. Kong is an open-source platform to manage and secure APIs and microservices.

Outside of SaaS there is a fair amount of activity within HealthTech and Fintech.

  • Jazz Pharmaceuticals acquires GW Pharmaceuticals for $7.2 billion. GW Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics.
  • Horizon Therapeutics acquires Viela Bio for $3.1 billion. Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.
  • Veracyte acquires Decipher Biosciences for $600 million. Decipher Biosciences offers a portfolio of genomic tests, continues to build the GRID database of over 70,000 whole transcriptome profiles, and is partnering with pharmaceutical companies to identify biomarkers of response to novel therapeutics.
  • Capital Rx receives $50 million in funding from Transformation Capital and Edison Partners. Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.
  • Stash receives $125 million in funding from Eldridge, T. Rowe Price, Owl Ventures, Goodwater Capital, and Entrée Capital. Stash is a personal finance app that combines banking, investing, and advice into one platform.
  • Flexiti Financial receives $121 million in funding from CURO Financial Technologies. Flexiti Financial is a Canadian fintech company that offers flexible sales financing solutions, enabling businesses to sell more while helping consumers enjoy the things they need and want sooner.
  • Built Technologies receives $88 million in funding from Addition, Zander Lurie (SurveyMonkey), Wilmington, Canapi Ventures, Index Ventures, Goldman Sachs Investment Partners, Nyca Partners, Fifth Wall Ventures, Nine Four Ventures, Jordan Park, Renegade Partners, Green Point Partners, Witkoff Group, Jackie Reses, Zander Lurie, Dan Goldsmith, and Lowell Putnam. Built Technologies is an enterprise technology company that provides cloud-based construction lending software.
  • LeaseLock receives $52 million in funding from Wildcat Venture Partners, Westerly Wind, Vertex US, Softbank Ventures Asia, Mucker Capital, Moderne Ventures, Liberty Mutual Strategic Ventures, and American Family Ventures. LeaseLock is the world’s leading insurtech platform for real estate that leverages artificial intelligence to eliminate security deposits from enterprise operating infrastructure — powering a faster, simpler, and more affordable rental transaction.
Unlisted

--

--